Navigation Links
RedVision Announces Integrated Client Workflow Platform: TitleVision2 'The Power of Two'
Date:4/27/2010

PARSIPPANY, N.J., April 27 /PRNewswire/ -- RedVision, a national provider of real property research solutions announced today the release of TitleVision2, a fully integrated production workflow solution for lenders, title underwriters, title agents, and default servicing professionals.

TitleVision2 is changing the way the real property research industry compiles, prepares and delivers real property reports and title examinations. This unique platform empowers RedVision clients to integrate and customize workflow tasks and production roles based on their individual needs. RedVision is turning high touch processes into automated functions by leveraging real estate data, ground breaking technology and more than 450 U.S. based employees and examiners.

"We are proud of our technology and the savings TitleVision2 provides each of our clients," said Brian Twibell, CEO of RedVision. "By integrating our production platform and experienced staff with our clients we enable each of them to utilize RedVision's professionals and make the best use of their staff. We are providing peace of mind that every touch point of a property report receives the highest skill level possible and quality standards are exceeded every step of the way. Creating a true strategic partnership is an unwavering goal for RedVision."  

TitleVision2 was created with "The Power of Two" in mind and the need to provide clients with reliable means to dealing with industry cycles and cost saving alternatives. The systems foundation was built from the RedVision geographically indexed title plant "TitleVision" and the internal production platform utilized by RedVision's staff. The key purpose behind the development of TitleVision2 was to supply clients with a solution for cost effective staffing and high quality reports. The system addresses an industry reality that staffing and production needs can change by the hour. At a moment's notice, clients can now select online access to the company's robust title plant while utilizing their own examination staff, or have access to the RedVision research and examination team. Clients can now completely customize the vendor relationship from order placement and research needs, to typing requirements and quality control standards all at the click of a button.

About RedVision

RedVision is an independent provider of real property research solutions, combining experts and technology to improve service levels and the bottom line. RedVision serves users of title evidence looking for relevant and accurate information to make sound business decisions relating to real property transactions. The company's revolutionary approach combines a distributed services workflow platform, a vast title plant database, and well-trained service experts to provide accurate, cost effective, and timely real property research services for its banking, title, and default and settlement service customers.


'/>"/>
SOURCE RedVision
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
Breaking Medicine News(10 mins):